Adult height in patients with congenital adrenal hyperplasia: A systematic review and metaanalysis

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 9, 2010, Pages 4161-4172

  Muthusamy, Kalpana ^a   Elamin, Mohamed B ^a   Smushkin, Galina ^a   Murad, Mohammad Hassan ^a   Lampropulos, Julianna F ^a   Elamin, Khalid B ^b   Abu Elnour, Nisrin O ^a   Gallegos Orozco, Juan F ^a,c   Fatourechi, Mitra M ^a   Agrwal, Neera ^a,c   Lane, Melanie A ^a   Albuquerque, Felipe N ^a   Erwin, Patricia J ^a   Montori, Victor M ^a  

^a MAYO CLINIC   (United States)

^b St Lukes General Hospital Kilkenny   (Ireland)

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; CORTISONE; CORTISONE ACETATE; DEOXYCORTICOSTERONE; DEXAMETHASONE; FLUDROCORTISONE; GLUCOCORTICOID; HYDROCORTISONE; HYDROXYPROGESTERONE; METHYLPREDNISOLONE; MINERALOCORTICOID; PRASTERONE; PREDNISOLONE; PREDNISONE; STEROID; HUMAN GROWTH HORMONE;

ADULT; BODY HEIGHT; BODY MASS; COCHRANE LIBRARY; COHORT ANALYSIS; CONGENITAL ADRENAL HYPERPLASIA; EMBASE; FOLLOW UP; HUMAN; MEDLINE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; SYSTEMATIC REVIEW; TREATMENT DURATION; ALGORITHM; GROWTH DISORDER; META ANALYSIS; PATHOPHYSIOLOGY; PHYSIOLOGY; TREATMENT OUTCOME;

SCOPUS;

ADRENAL HYPERPLASIA, CONGENITAL; ADULT; ALGORITHMS; BODY HEIGHT; GLUCOCORTICOIDS; GROWTH DISORDERS; HUMAN GROWTH HORMONE; HUMANS; MINERALOCORTICOIDS; TREATMENT OUTCOME;

EID: 77956592186     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-2616     Document Type: Review

References (54)

1. Merke DP, Bornstein SR 2005 Congenital adrenal hyperplasia. Lancet 365:2125-2136
2. Therrell Jr BL, Berenbaum SA, Manter-Kapanke V, Simmank J, Korman K, Prentice L, Gonzalez J, Gunn S 1998 Results of screening 1.9 million Texas newborns for 21-hydroxylase-deficient congenital adrenal hyperplasia. Pediatrics 101:583-590
3. Muirhead S, Sellers EA, Guyda H 2002 Indicators of adult height outcome in classical 21-hydroxylase deficiency congenital adrenal hyperplasia. J Pediatr 141:247-252
4. Pincus DR, Kelnar CJ, Wallace AM 1993 17-Hydroxyprogesterone rhythms and growth velocity in congenital adrenal hyperplasia. J Paediatr Child Health 29:302-304
5. Soliman AT, AlLamki M, AlSalmi I, Asfour M 1997 Congenital adrenal hyperplasia complicated by central precocious puberty: linear growth during infancy and treatment with gonadotropin-releasing hormone analog. Metabolism 46:513-517
6. Eugster EA, Dimeglio LA, Wright JC, Freidenberg GR, Seshadri R, Pescovitz OH 2001 Height outcome in congenital adrenal hyperplasia caused by 21-hydroxylase deficiency: a meta-analysis. J Pediatr 138:26-32
7. Moher D, Liberati A, Tetzlaff J, Altman DG 2009 Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339:b2535
8. Speiser PW, Azziz R, Baskin LS, Ghizzoni L, Hensle TW, Merke DP, Meyer-Bahlburg HFL, Miller WL, Montori VM, Oberfield SE, Ritzen M, White PC 2010 Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an endocrine clinical practice guideline. J Clin Endocrinol Metab 95:4133-4160
9. DerSimonian R, Laird N 1986 Meta-analysis in clinical trials. Control Clin Trials 7:177-188
10. Bergstrand CG 1966 Growth in congenital adrenal hyperplasia. Acta Paediatr Scand 55:463-472
11. David M, Sempé M, Blanc M, Nicolino M, Forest MG, Morel Y 1994 Final height in 69 patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Arch Pediatr 1:363-367
12. Gussinyé M, Potau N, Vicens-Calvet E, Albisu MA, Yeste D, Ibáñez L, Audí L, Carrascosa A 1997 Adult height, pattern of growth and pubertal development in patients with congenital adrenal hyperplasia, salt losing form. Med Clin 108:87-90
13. Kirkland RT, Keenan BS, Holcombe JH, Kirkland JL, Clayton GW 1978 The effect of therapy on mature height in congenital adrenal hyperplasia. J Clin Endocrinol Metab 47:1320-1324
14. Tanner JM, Goldstein H, Whitehouse RH 1970 Standards for children's height. Arch Dis Child 45:755-762
15. Higgins JP, Thompson SG, Deeks JJ, Altman DG 2003 Measuring inconsistency in meta-analyses. BMJ 327:557-560
16. Altman DG, Bland JM 2003 Interaction revisited: the difference between two estimates. BMJ 326:219
17. Balsamo A, Cicognani A, Baldazzi L, Barbaro M, Baronio F, Gennari M, Bal M, Cassio A, Kontaxaki K, Cacciari E 2003 CYP21 genotype, adult height, and pubertal development in 55 patients treated for 21-hydroxylase deficiency. J Clin Endocrinol Metab [Erratum (2004) 89:5409] 88:5680-5688
18. Gschwend S, Lee PA 1993 Adult height and menstrual history among patients with classical 21-hydroxylase deficiency adrenal hyperplasia: Correlation with growth and therapy during development. Adolesc Pediatr Gynecol 6:209-213
19. Premawardhana LD, Hughes IA, Read GF, Scanlon MF 1997 Longer term outcome in females with congenital adrenal hyperplasia (CAH): the Cardiff experience. Clin Endocrinol (Oxf) 46:327-332
20. van der Kamp HJ, Slijper FM, Brandenburg H, de Muinck Keizer-Schrama SM, Drop SL, Molenaar JC 1992 Evaluation of young women with congenital adrenal hyperplasia: a pilot study. Horm Res 37(Suppl 3):45-49
21. Yu AC, Grant DB 1995 Adult height in women with early-treated congenital adrenal hyperplasia (21-hydroxylase type): relation to body mass index in earlier childhood. Acta Paediatr 84:899-903
22. Gargantini L, Calzi P, Brunelli V, Braggion F, Chiumello G 1989 [Growth and puberal development in males with adreno-genital syndrome]. Pediatr Med Chir 11:597-602 (Italian)
23. Bajpai A, Pandey RM, Kabra M, Menon PS 2007 Growth pattern and final height in 21-hydroxylase deficiency. Indian Pediatr 44:771-773
24. Kolousková S, Zemková D, Snajderová M, Lebl J 1995 [Growth and adult height in patients with congenital adrenal hyperplasia]. Cas Lek Cesk 134:689-691 (Czech)
25. Manoli I, Kanaka-Gantenbein C, Voutetakis A, Maniati-Christidi M, Dacou-Voutetakis C 2002 Early growth, pubertal development, body mass index and final height of patients with congenital adrenal hyperplasia: factors influencing the outcome. Clin Endocrinol (Oxf) 57:669-676
26. Sciannamblo M, Russo G, Cuccato D, Chiumello G, Mora S 2006 Reduced bone mineral density and increased bone metabolism rate in young adult patients with 21-hydroxylase deficiency. J Clin Endocrinol Metab 91:4453-4458
27. Stikkelbroeck NM, Oyen WJ, van der Wilt GJ, Hermus AR, Otten BJ 2003 Normal bone mineral density and lean body mass, but increased fat mass, in young adult patients with congenital adrenal hyperplasia. J Clin Endocrinol Metab 88:1036-1042
28. Tanae A, Hibi I 1988 Unresolved problems in the treatment of congenital adrenal hyperplasia. Acta Paediatr Jpn 30:93-98
29. Lim YJ, Batch JA, Warne GL 1995 Adrenal 21-hydroxylase deficiency in childhood: 25 years' experience. J Paediatr Child Health 31:222-227
30. Gandhi GY, Murad MH, Fujiyoshi A, Mullan RJ, Flynn DN, Elamin MB, Swiglo BA, Isley WL, Guyatt GH, Montori VM 2008 Patient-important outcomes in registered diabetes trials. JAMA 299:2543-2549
31. Swiglo BA, Murad MH, Schünemann HJ, Kunz R, Vigersky RA, Guyatt GH, Montori VM 2008 A case for clarity, consistency, and helpfulness: state-of-the-art clinical practice guidelines in endocrinology using the grading of recommendations, assessment, development, and evaluation system. J Clin Endocrinol Metab 93:666-673
32. Bonfig W, Pozza SB, Schmidt H, Pagel P, Knorr D, Schwarz HP 2009 Hydrocortisone dosing during puberty in patients with classical congenital adrenal hyperplasia: an evidence-based recommendation. J Clin Endocrinol Metab 94:3882-3888
33. Quintos JB, Vogiatzi MG, Harbison MD, New MI 2001 Growth hormone therapy alone or in combination with gonadotropin-releasing hormone analog therapy to improve the height deficit in children with congenital adrenal hyperplasia. J Clin Endocrinol Metab 86:1511-1517
34. Lin-Su K, Vogiatzi MG, Marshall I, Harbison MD, Macapagal MC, Betensky B, Tansil S, New MI 2005 Treatment with growth hormone and luteinizing hormone releasing hormone analog improves final adult height in children with congenital adrenal hyperplasia. J Clin Endocrinol Metab 90:3318-3325
35. Saenger P 2000 The case in support of GH therapy. J Pediatr 136:106-109; discussion 109-110
36. Cohen S 2010 Too tall, too small? The temptation to tinker with a child's height. Lancet 454-455
37. Sandberg DE, Bukowski WM, Fung CM, Noll RB 2004 Height and social adjustment: are extremes a cause for concern and action? Pediatrics 114:744-750
38. Jääskeläinen J, Voutilainen R 1997 Growth of patients with 21-hydroxylase deficiency: an analysis of the factors influencing adult height. Pediatric research 41:30-33
39. Grigorescu-Sido A, Bettendorf M, Schulze E, Duncea I, Heinrich U 2003 Growth analysis in patients with 21-hydroxylase deficiency influence of glucocorticoid dosage, age at diagnosis, phenotype and genotype on growth and height outcome. Hormone Research 60:84-90
40. Hargitai G, Só lyom J, Battelino T, Lebl J, Pribilincová Z, Hauspie R, Ková cs J, Waldhauser F, Frisch H 2001 Growth patterns and final height in congenital adrenal hyperplasia due to classical 21-hydroxylase deficiency. Results of a multicenter study. Horm Res 55:161-171
41. Aycan Z, Ocal G, Berberoglu M, Cetinkaya E, Adiyaman P, Evliyaoglu O 2006 Experience with long-term glucocorticoid treatment in congenital adrenal hyperplasia: growth pattern compared with genetic height potential. J Pediatr Endocrinol Metab 19:245-251
42. Bonfig W, Bechtold S, Schmidt H, Knorr D, Schwarz HP 2007 Reduced final height outcome in congenital adrenal hyperplasia under prednisone treatment: deceleration of growth velocity during puberty. see comment. J Clin Endocrinol Metab 92:1635-1639
43. Cameron FJ, Kaymakci B, Byrt EA, Ebeling PR, Warne GL, Wark JD 1995 Bone mineral density and body composition in congenital adrenal hyperplasia. J Clin Endocrinol Metab 80:2238-2243
44. DiMartino-Nardi J, Stoner E, O'Connell A, New MI 1986 The effect of treatment of final height in classical congenital adrenal hyperplasia (CAH). Acta Endocrinol Suppl (Copenh) 279:305-314
45. Hoepffner W, Kaufhold A, Willgerodt H, Keller E 2008 Patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency can achieve their target height: The Leipzig experience. Horm Res 70:42-50
46. Jääskeläinen J, Voutilainen R 1996 Bone mineral density in relation to glucocorticoid substitution therapy in adult patients with 21-hydroxylase deficiency. Clinical endocrinology 45:707-713
47. Klingensmith GJ, Garcia SC, Jones HW, Migeon CJ, Blizzard RM 1977 Glucocorticoid treatment of girls with congenital adrenal hyperplasia: effects on height, sexual maturation, and fertility. J Pediatr 90:996-1004
48. Lemos-Marini SH, Guerra-Jú nior G, Morcillo AM, Baptista MT, Silva LO, Maciel-Guerra AT 2005 [Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: final height in 27 patients with the classical form]. Arq Bras Endocrinol Metabol 49:902-907
49. New MI, Gertner JM, Speiser PW, del Balzo P 1988 Growth and final height in classical and nonclassical 21-hydroxylase deficiency. Acta Paediatr Jpn 30:79-88
50. Pasqualini T, Alonso G, Tomasini R, Galich AM, Buzzalino N, Fernandez C, Minutolo C, Alba L, Dain L 2007 Congenital adrenal hyperplasia. Clinical characteristics and genotype in newborn, childhood and adolescence. Medicina (B Aires) 67:253-261
51. Pinto G, Tardy V, Trivin C, Thalassinos C, Lortat-Jacob S, Nihoul-Fékété C, Morel Y, Brauner R 2003 Follow-up of 68 children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: relevance of genotype for management. J Clin Endocrinol Metab 88:2624-2633
52. Trinh L, Nimkarn S, New MI, Lin-Su K 2007 Growth and pubertal characteristics in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Pediatr Endocrinol Metab 20:883-891 (Pubitemid 47455348)
53. Van der Kamp HJ, Otten BJ, Buitenweg N, De Muinck Keizer-Schrama SM, Oostdijk W, Jansen M, Delemarre-de Waal HA, Vulsma T, Wit JM 2002 Longitudinal analysis of growth and puberty in 21-hydroxylase deficiency patients. Arch Dis Child 87:139-144
54. Young MC, Ribeiro J, Hughes IA 1989 Growth and body proportions in congenital adrenal hyperplasia. Arch Dis Child 64:1554-1558